Healthscope has unanimously recommended shareholders accept an offer by a US consortium of $6.26 a share to buy the company." />

Healthscope poised to accept offer from TPG and Carlyle

By David Binning
Tuesday, 20 July, 2010

The board of private Australian healthcare provider Healthscope has unanimously recommended shareholders accept an offer by a US consortium of $6.26 a share to buy the company.

Texas Pacific Group (TPG) and the Carlyle Group are two of the world’s largest private equity firms, together managing over $US135 billion in equity capital. Their offer follows a formal evaluation process between the parties and values Healthscope at $2.7 billion, a 39 percent premium on the company’s closing price of $4.50 the day before the offer was made on May 13 this year.

The consortium had earlier confirmed that it planned to retain Healthscope managing director Bruce Dixon along with other senior managers.

With 44 private hospitals spread throughout every Australian state and territory, Healthscope is the country’s second largest private healthcare provider behind Ramsay Health.

Healthscope shares were up one cent to $5.95 by early afternoon trade.

Related News

Defective sperm doubles pre-eclampsia risk in IVF patients

A high proportion of the father's spermatozoa possessing DNA strand breaks is associated with...

Free meningococcal B vaccines coming to the NT

The Northern Territory Government has confirmed the rollout of a free meningococcal B vaccine...

Mouth bacteria linked to increased head and neck cancer risk

More than a dozen bacterial species that live in people's mouths have been linked to a...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd